The paradox of cancer genes in non-malignant conditions: implications for precision medicine
Abstract Next-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures. Intriguingly, rapidly emerging data indicate that altered genes representing oncogenic drivers can also be found i...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2020-02-01
|
| Series: | Genome Medicine |
| Online Access: | http://link.springer.com/article/10.1186/s13073-020-0714-y |